The University of Colorado Anschutz Medical Campus will receive up to $46 million from the Advanced Research Projects Agency for Health (ARPA-H) Transplantation of Human Eye Allografts (THEA) program to advance pioneering research aimed at curing total blindness through human eye transplantation.
The award will support the work of the Total Human Eye-allotransplantation Innovation Advancement (THEIA) project team led by CU.
The project is led by principal investigator and surgeon-scientist Kia Washington, MD, and co-principal investigator Christene A. Huang, PhD, transplant immunologist. Both are professors at the University of Colorado School of Medicine and are nationally recognized leaders in plastic and reconstruction surgery, transplant surgery and immunology.
Ähnliche Beiträge
Donald Trump and Narcissistic Traits: What the Research Shows
Research examining Donald Trump’s personality focuses exclusively on observable public behavior, expert ratings, content analyses of speeches and debates, and voter perceptions. Ethical standards in…
Biomarker in der Präzisionsmedizin: Die „Shooting Stars“ bis 2026
Die Präzisionsmedizin entwickelt sich rasant hin zu multi-modalen, minimal-invasiven und KI-gestützten Biomarkern. Diese ermöglichen eine frühere Diagnose, präzisere Therapieauswahl und Echtzeit-Überwachung von Erkrankungen. Im Fokus…
Boehringer Ingelheim meldet positive Phase-III-Ergebnisse für Survodutide bei Adipositas
Ingelheim (Labnews Media LLC) – Boehringer Ingelheim hat positive Topline-Ergebnisse aus der Phase-III-Studie SYNCHRONIZE-1 mit dem dualen Glucagon/GLP-1-Rezeptor-Agonisten Survodutide (BI 456906) vorgelegt. Erwachsene mit Adipositas…
